JP7370870B2 - プールヒト血小板溶解物を調製するための方法、プールヒト血小板溶解物、及び神経障害を処置するためのその使用 - Google Patents

プールヒト血小板溶解物を調製するための方法、プールヒト血小板溶解物、及び神経障害を処置するためのその使用 Download PDF

Info

Publication number
JP7370870B2
JP7370870B2 JP2019569741A JP2019569741A JP7370870B2 JP 7370870 B2 JP7370870 B2 JP 7370870B2 JP 2019569741 A JP2019569741 A JP 2019569741A JP 2019569741 A JP2019569741 A JP 2019569741A JP 7370870 B2 JP7370870 B2 JP 7370870B2
Authority
JP
Japan
Prior art keywords
phpl
treated
heat
pooled human
human platelet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019569741A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020523398A5 (https=
JP2020523398A (ja
Inventor
ダヴィド・ドゥヴォス
ティエリー・ビュルヌーフ
ジャン－クリストフ・ドゥヴジャン
ミン－リ・チョウ
フロール・グエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of JP2020523398A publication Critical patent/JP2020523398A/ja
Publication of JP2020523398A5 publication Critical patent/JP2020523398A5/ja
Application granted granted Critical
Publication of JP7370870B2 publication Critical patent/JP7370870B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2019569741A 2017-06-16 2018-06-15 プールヒト血小板溶解物を調製するための方法、プールヒト血小板溶解物、及び神経障害を処置するためのその使用 Active JP7370870B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17305739 2017-06-16
EP17305739.9 2017-06-16
PCT/EP2018/066020 WO2018229278A1 (en) 2017-06-16 2018-06-15 Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders

Publications (3)

Publication Number Publication Date
JP2020523398A JP2020523398A (ja) 2020-08-06
JP2020523398A5 JP2020523398A5 (https=) 2021-07-29
JP7370870B2 true JP7370870B2 (ja) 2023-10-30

Family

ID=59269973

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019569741A Active JP7370870B2 (ja) 2017-06-16 2018-06-15 プールヒト血小板溶解物を調製するための方法、プールヒト血小板溶解物、及び神経障害を処置するためのその使用

Country Status (10)

Country Link
US (1) US11744863B2 (https=)
EP (1) EP3638263B1 (https=)
JP (1) JP7370870B2 (https=)
CN (1) CN110891582A (https=)
AU (1) AU2018284011B2 (https=)
BR (1) BR112019026846A2 (https=)
CA (1) CA3067294A1 (https=)
ES (1) ES2955282T3 (https=)
IL (1) IL271436B2 (https=)
WO (1) WO2018229278A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途
JP2022519781A (ja) * 2019-02-07 2022-03-24 バイオブリッジ グローバル 血小板放出物および多血小板フィブリンに関する方法および組成物
EP3881858A1 (en) * 2020-03-20 2021-09-22 Rok Pangersic Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect
WO2023103744A1 (zh) * 2021-12-07 2023-06-15 无限发展有限公司 血小板内生长因子的提取方法
EP4276173A1 (en) 2022-05-10 2023-11-15 Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. Stable human platelet lysate composition, methods and uses thereof
KR20250108745A (ko) * 2022-12-02 2025-07-15 누와셀 바이오테크놀로지 코., 엘티디. 중뇌 도파민 작동성 전구 세포의 제조를 위한 배양 배지, 코팅 매트릭스 및 방법
TWI909123B (zh) 2022-12-30 2025-12-21 思必瑞特生技股份有限公司 含血小板之組合物及其製備方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014522833A (ja) 2011-06-27 2014-09-08 エモリー ユニバーシティ 血小板溶解物の組成物、用途および調製
JP2016529283A (ja) 2013-08-27 2016-09-23 クック・ジェネラル・バイオテクノロジー・エルエルシー 濃厚血小板から誘導可能な生理活性組成物並びにその調製方法及び使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2006632A6 (es) 1987-04-21 1989-05-01 Green Cross Corp Procedimiento de tratamiento termico de fibrinogeno.
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
WO2008034803A1 (en) * 2006-09-18 2008-03-27 Medizinische Universität Graz Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
EP2389942B1 (en) * 2010-05-25 2013-01-23 GwoWei Technology Co., Ltd. Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
US20140176602A1 (en) 2011-08-18 2014-06-26 Nec Corporation Information processing system, information processing method, information processing apparatus, and control method and control program thereof
EP3848058A1 (en) * 2012-12-20 2021-07-14 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014522833A (ja) 2011-06-27 2014-09-08 エモリー ユニバーシティ 血小板溶解物の組成物、用途および調製
JP2016529283A (ja) 2013-08-27 2016-09-23 クック・ジェネラル・バイオテクノロジー・エルエルシー 濃厚血小板から誘導可能な生理活性組成物並びにその調製方法及び使用方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BIOMATERIALS，2013年，34，7840-7850
CHOU ML.，Dedicated, virally-inactivated, platelet lysates and platelet microparticles in regenerative medicine and neuroprotective therapies，Human health and pathology. Universite du Droit et de la Sante - Lille II; Taipei medical university (Taipei)，2016年，https://tel.archives-ouvertes.fr/tel-01973786
FLORE GOUEL，THE PROTECTIVE EFFECT OF HUMAN PLATELET LYSATE IN MODELS OF NEURODEGENERATIVE 以下備考，JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE，米国，2016年，VOL:11，PAGE(S):3236 - 3240，https://pubmed.ncbi.nlm.nih.gov/27943621/，DISEASE: INVOLVEMENT OF THE AKT AND MEK PATHWAYS
Thrombosis and Haemostasis，2013年，Vol 110, No.2，323-330
YE CHIN CHOI; GREGORY M MORRIS; LEON SOKOLOFF，EFFECT OF PLATELET LYSATE ON GROWTH AND SULFATED GLYCOSAMINOGLYCAN SYNTHESIS IN ARTICULAR 以下備考，ARTHRITIS & RHEUMATISM，米国，1980年，VOL:23, NR:2，PAGE(S):220 - 224，http://dx.doi.org/10.1002/art.1780230213，CHONDROCYTE CULTURES

Also Published As

Publication number Publication date
RU2020101295A3 (https=) 2022-02-24
US11744863B2 (en) 2023-09-05
CN110891582A (zh) 2020-03-17
AU2018284011A1 (en) 2020-01-16
EP3638263C0 (en) 2023-08-23
CA3067294A1 (en) 2018-12-20
BR112019026846A2 (pt) 2020-06-30
AU2018284011B2 (en) 2024-05-30
IL271436B2 (en) 2024-02-01
US20200113942A1 (en) 2020-04-16
ES2955282T3 (es) 2023-11-29
IL271436B1 (en) 2023-10-01
JP2020523398A (ja) 2020-08-06
EP3638263B1 (en) 2023-08-23
RU2020101295A (ru) 2021-07-16
EP3638263A1 (en) 2020-04-22
WO2018229278A1 (en) 2018-12-20
IL271436A (en) 2020-01-30

Similar Documents

Publication Publication Date Title
JP7370870B2 (ja) プールヒト血小板溶解物を調製するための方法、プールヒト血小板溶解物、及び神経障害を処置するためのその使用
JP7210465B2 (ja) 成長因子含有血小板放出物を調製する方法
AU2017238476B2 (en) Preparation of platelet pellet lysate and its use for treating neurological disorders
BR112020006316A2 (pt) processo para preparar uma fração de lisado de plaquetas, fração de lisado de plaquetas e seu uso para tratar transtornos do sistema nervoso central
RU2802440C2 (ru) Способ получения объединенного лизата тромбоцитов человека, объединенный лизат тромбоцитов человека и его применение для лечения неврологических нарушений
RU2795884C2 (ru) Способ получения релизата тромбоцитов, содержащего факторы роста
HK1195486A (en) Viral inactivated platelet extract, use and preparation thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210611

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210611

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220920

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221121

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230410

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230707

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230919

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231018

R150 Certificate of patent or registration of utility model

Ref document number: 7370870

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150